Find the Perfect Plan for Your Investment Journey
H
Latest price
52 Week Range
A$1.08 - A$1.86
Next Earnings Date
Aug 19 2025 (Estimate)
Next Earnings Date
Aug 19 2025 (Est.)
Latest price
Market Cap | A$1.01B |
EV | A$2.29B |
Shares Outstanding | 726.13M |
Beta | 0.63 |
Analyst Rating | HOLD |
Analyst Target Price | A$1.35 |
P/E 2025E | 265.36x |
P/Revenue 2025E | 0.73x |
Revenue | -2.80% |
EPS | - |
Operating Cash Flow | -14.50% |
Free Cash Flow | -17.10% |
Revenue | -5.40% |
EPS | - |
Operating Cash Flow | 1.30% |
Free Cash Flow | 7.30% |
Gross Margin 2025E | 84.00% |
Net Profit Margin 2025E | 17.85% |
ROE 2025E | 4.28% |
ROCE 2024 | -49.94% |
DPS 2025E | A$0.18 |
Payout Ratio 2025E | -600.00% |
Div. Yield 2025E | 12.98% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
H
Healius Limited
HLS
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Anderson, Paul
Employees
6,994
Website
www.healius.com.auIPO Date
1998-08-03
Headquarters
161 Castlereagh Street, Level 22, Sydney, New South Wales, 2000, Australia
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved